These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 29882175)

  • 1. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.
    Ryan L; Golparian D; Fennelly N; Rose L; Walsh P; Lawlor B; Mac Aogáin M; Unemo M; Crowley B
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1661-1672. PubMed ID: 29882175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.
    Gianecini RA; Golparian D; Zittermann S; Litvik A; Gonzalez S; Oviedo C; Melano RG; Unemo M; Galarza P;
    J Antimicrob Chemother; 2019 Jun; 74(6):1551-1559. PubMed ID: 30820563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014.
    Jacobsson S; Golparian D; Cole M; Spiteri G; Martin I; Bergheim T; Borrego MJ; Crowley B; Crucitti T; Van Dam AP; Hoffmann S; Jeverica S; Kohl P; Mlynarczyk-Bonikowska B; Pakarna G; Stary A; Stefanelli P; Pavlik P; Tzelepi E; Abad R; Harris SR; Unemo M
    J Antimicrob Chemother; 2016 Nov; 71(11):3109-3116. PubMed ID: 27432597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014.
    Demczuk W; Martin I; Peterson S; Bharat A; Van Domselaar G; Graham M; Lefebvre B; Allen V; Hoang L; Tyrrell G; Horsman G; Wylie J; Haldane D; Archibald C; Wong T; Unemo M; Mulvey MR
    J Clin Microbiol; 2016 May; 54(5):1304-13. PubMed ID: 26935729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
    Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
    BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.
    Liang JY; Cao WL; Li XD; Bi C; Yang RD; Liang YH; Li P; Ye XD; Chen XX; Zhang XB
    BMC Infect Dis; 2016 Apr; 16():152. PubMed ID: 27080231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
    Lee RS; Seemann T; Heffernan H; Kwong JC; Gonçalves da Silva A; Carter GP; Woodhouse R; Dyet KH; Bulach DM; Stinear TP; Howden BP; Williamson DA
    J Antimicrob Chemother; 2018 Feb; 73(2):353-364. PubMed ID: 29182725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.
    Lee H; Unemo M; Kim HJ; Seo Y; Lee K; Chong Y
    J Antimicrob Chemother; 2015 Sep; 70(9):2536-42. PubMed ID: 26084303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of high-level azithromycin-resistant
    Müller EE; Gumede LYE; Maseko DV; Mahlangu MP; Venter JME; Da Costa Dias B; Nhlapho D; Kularatne RS
    Sex Health; 2024 Feb; 21(1):NULL. PubMed ID: 38029797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.
    Demczuk W; Lynch T; Martin I; Van Domselaar G; Graham M; Bharat A; Allen V; Hoang L; Lefebvre B; Tyrrell G; Horsman G; Haldane D; Garceau R; Wylie J; Wong T; Mulvey MR
    J Clin Microbiol; 2015 Jan; 53(1):191-200. PubMed ID: 25378573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Whole Genome Sequencing for the Molecular Comparison of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended Spectrum Cephalosporins From 2 Geographically Different Regions in America.
    Gianecini RA; Zittermann S; Oviedo C; Galas M; Pardo PR; Allen VG; Galarza P; Melano RG
    Sex Transm Dis; 2019 Aug; 46(8):548-555. PubMed ID: 31295224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
    Thakur SD; Levett PN; Horsman GB; Dillon JA
    Sex Transm Infect; 2014 Jun; 90(4):297-302. PubMed ID: 24503900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
    Golparian D; Bazzo ML; Ahlstrand J; Schörner MA; Gaspar PC; de Melo Machado H; Martins JM; Bigolin A; Ramos MC; Ferreira WA; Pereira GFM; Miranda AE; Unemo M;
    J Antimicrob Chemother; 2024 May; 79(5):1081-1092. PubMed ID: 38517452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015.
    Wind CM; Bruisten SM; Schim van der Loeff MF; Dierdorp M; de Vries HJC; van Dam AP
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 49.